Role of topical tretinoin in melanoma and dysplastic nevi.
暂无分享,去创建一个
[1] N. Levine. Effects of topical retinoic acid on intracutaneously implanted S91 melanoma in mice. , 1985, The Journal of investigative dermatology.
[2] I. Jacoby. Precursors to malignant melanoma. , 1985, JAMA.
[3] H. Lynch,et al. National Institutes of Health consensus report on precursors to malignant melanoma. A difference in opinion. , 1984, JAMA.
[4] K. Arndt. Precursors to malignant melanoma: congenital and dysplastic nevi. , 1984, JAMA.
[5] W. Clark,et al. MANAGING THE DYSPLASTIC NAEVUS SYNDROME , 1984, The Lancet.
[6] G. Cage,et al. Precursors to malignant melanoma. National Institutes of Health Consensus Development Conference Statement, Oct. 24-26, 1983. , 1984, Journal of the American Academy of Dermatology.
[7] F. Meyskens,et al. Dexamethasone, prostaglandin A, and retinoic acid modulation of murine and human melanoma cells grown in soft agar. , 1983, Journal of the National Cancer Institute.
[8] E. Vellenga,et al. EFFECTIVE PROPHYLAXIS WITH ORAL ANTICOAGULANTS AND LOW-DOSE HEPARIN DURING PREGNANCY IN AN ANTITHROMBIN III DEFICIENT WOMAN , 1983, The Lancet.
[9] W. Clark,et al. The dysplastic nevus syndrome: our definition. , 1982, The American Journal of dermatopathology.
[10] R. Deitch. Implications of in-vitro fertilisation. , 1982, Lancet.
[11] Hill Dl,et al. Retinoids as chemopreventive and anticancer agents intact animals (review). , 1982 .
[12] C. Grubbs,et al. Retinoids as chemopreventive and anticancer agents intact animals (review). , 1982, Anticancer research.
[13] F. Meyskens. Modulation of abnormal growth by retinoids: a clinical perspective of the biological phenomenon. , 1981, Life sciences.
[14] W. Clark,et al. Topical chemotherapy of dysplastic melanocytic nevi with 5% fluorouracil. , 1981, Archives of dermatology.
[15] F. Meyskens,et al. TOPICAL VITAMIN-A-ACID THERAPY FOR CUTANEOUS METASTATIC MELANOMA , 1980, The Lancet.
[16] F. Meyskens,et al. Characterization of the effects of different retinoids on the growth and differentiation of a human melanoma cell line and selected subclones. , 1980, Cancer research.
[17] R. Lotan. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. , 1980, Biochimica et biophysica acta.
[18] S. Salmon,et al. Inhibition of human melanoma colony formation by retinoids. , 1979, Cancer research.
[19] R. Lotan. Different susceptibilities of human melanoma and breast carcinoma cell lines to retinoic acid-induced growth inhibition. , 1979, Cancer research.
[20] R. Lotan,et al. Characterization of the inhibitory effects of retinoids on the in vitro growth of two malignant murine melanomas. , 1978, Journal of the National Cancer Institute.
[21] W. Clark,et al. Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'. , 1978, Archives of dermatology.
[22] W. Clark,et al. Precursor lesions in familial melanoma. , 1978, Seminars in oncology.
[23] H. Lynch,et al. NEW CUTANEOUS PHENOTYPE IN FAMILIAL MALIGNANT MELANOMA , 1977, The Lancet.
[24] M. Sporn,et al. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). , 1976, Federation proceedings.
[25] Atta Ae. Letter: Perinatal mortality. , 1974 .